Drawing for KTI

USPTO serial 88109082

KTI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WINTER, MELISSA S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KTI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles A. Meeker

Charles A. Meeker Workman Nydegger60 East South Temple, Suite 1000Salt Lake City, UT 84111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for increasing concentration of protein in a human patient; veterinary preparations for increasing concentration of protein in a mammalian animal subject; nutraceuticals for increasing protein production in a human subject; nutraceuticals for use as a dietary supplement; nutraceuticals for use as a dietary supplement for increasing protein levelsACTIVE—
010diagnostic kits, namely, medical diagnostic kits and biological diagnostic kits for use in diagnostics, namely, for quantification of blood sample components in the nature of proteins, consisting primarily of blood sample collection equipment in the nature of medical sample tubes and vials for collection and testing of blood samplesACTIVE—
035online retail store services featuring diagnostic kits in the nature of medical diagnostic kits and biological diagnostic kits for testing of biological samples; online retail store services featuring pharmaceutical preparations; online retail store services featuring veterinary preparationsACTIVE—
044medical services; veterinary services; diagnostic services, namely, medical diagnostic testing services; veterinary diagnostic services, namely, veterinary specialty services providing advanced veterinary diagnostic services for animals; medical diagnostic monitoring and reporting servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 10, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 10, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 29, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 28, 2022EX5GSOU EXTENSION 5 GRANTED—
Dec 28, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 9, 2022EXT5SOU EXTENSION 5 FILED—
Dec 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 9, 2022EX4GSOU EXTENSION 4 GRANTED—
Jun 9, 2022EXT4SOU EXTENSION 4 FILED—
Jun 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 9, 2021EX3GSOU EXTENSION 3 GRANTED—
Dec 9, 2021EXT3SOU EXTENSION 3 FILED—
Dec 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 2, 2021EXT2SOU EXTENSION 2 FILED—
Jun 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 9, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 7, 2020EX1GSOU EXTENSION 1 GRANTED—
Dec 7, 2020EXT1SOU EXTENSION 1 FILED—
Dec 7, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 11, 2020ALIEASSIGNED TO LIE—
Mar 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 24, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 24, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 24, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 1, 2020DOCKASSIGNED TO EXAMINER—
Dec 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2018DOCKASSIGNED TO EXAMINER—
Sep 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance